scPharmaceuticals Inc. logo SCPH - scPharmaceuticals Inc.

Inactive Ticker SCPH is not actively trading. Quotes and analytics may be stale.
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 5
HOLD 3
SELL 0
STRONG
SELL 0
| PRICE TARGET: $8.12 DETAILS
HIGH: $13.00
LOW: $5.35
MEDIAN: $6.00
CONSENSUS: $8.12
UPSIDE: 43.21%
Annual Quarterly
Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue 36.3 13.6 0 0 0 0 0 0 0 0
Cost of Revenue 11.4 3.8 0.5 0.4 0.4 0.4 0.3 0.2 0.0 0.0
Gross Profit 25.0 9.8 (0.5) (0.4) (0.4) (0.4) (0.3) (0.2) (0.0) (0.0)
Operating Expenses
R&D Expenses 12.1 11.8 15.5 16.0 18.1 24.6 15.9 14.3 11.9 8.3
SG&A Expenses 77.6 53.4 20.6 9.8 11.8 8.3 13.7 9.1 6.1 2.6
Other Expenses 0 0 0 0 0 0 (0.1) 0.1 0.0 (0.1)
Operating Expenses 89.7 65.2 36.2 25.8 29.9 32.9 29.7 23.4 17.9 10.8
Operating Income
Operating Income (64.8) (55.4) (36.2) (25.8) (29.9) (32.9) (29.7) (23.4) (17.9) (10.8)
Interest Expense 7.6 8.1 3.3 2.6 2.6 1.8 1.4 0.8 6.5 0
Interest Income 3.4 5.1 1.2 0.0 0.3 1.7 1.7 0.3 0.0 0
Profitability
EBITDA (77.4) (46.1) (33.1) (25.0) (29.2) (30.9) (27.7) (25.2) (17.9) (10.8)
EBIT (77.6) (46.7) (33.5) (25.5) (29.6) (31.2) (28.0) (23.4) (17.9) (10.8)
Income Before Tax (85.1) (54.8) (36.8) (28.0) (32.2) (33.0) (29.4) (23.8) (24.4) (10.5)
Income Tax Expense 0 0 0 0 0 0 (0.2) 0 0 0
Net Income (85.1) (54.8) (36.8) (28.0) (32.2) (34.4) (29.4) (23.8) (24.4) (10.5)
Per Share Data
EPS (Basic) -1.91 -1.42 -1.30 -1.02 -1.31 -1.85 -1.59 -8.04 -2.18 -0.94
EPS (Diluted) -1.91 -1.42 -1.30 -1.02 -1.31 -1.85 -1.59 -8.04 -2.18 -0.94
Shares Outstanding 44.5 38.5 28.4 27.4 24.6 18.6 18.6 3.0 11.2 11.2
Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Current Assets
Cash & Cash Equivalents 75.7 46.8 71.1 74.3 71.8 72.8 89.7 118.3 39.3 1.6
Short-Term Investments 0 29.2 47.1 1.0 33.3 0 0 0 0 0
Net Receivables 11.7 4.5 0 0 0 0.3 0.5 0.7 0.3 0.1
Inventory 13.9 8.8 1.2 0 0 2.4 1.6 0.8 0.1 0.1
Other Current Assets 1.0 1.2 1.4 0.0 (0.1) (2.5) 0.2 0.1 0.0 0.0
Total Current Assets 105.8 92.9 123.3 78.3 107.8 75.6 91.9 119.9 39.7 1.8
Non-Current Assets
Property, Plant & Equipment 1.3 1.5 0.6 0.5 0.9 1.3 1.7 2.0 0.0 0.0
Goodwill 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0.2 0 0 0 0
Other Non-Current Assets 0.3 0.1 0.3 0.3 0.3 0.1 0.2 0.2 0.0 0.0
Total Non-Current Assets 1.7 1.5 0.9 0.8 1.2 1.6 1.9 2.2 0.0 0.0
Total Assets 107.5 94.5 124.2 79.0 109.0 77.3 93.8 122.0 39.8 1.8
Current Liabilities
Account Payables 3.9 4.0 1.5 0.5 1.7 1.1 0.6 1.6 1.5 0.7
Short-Term Debt 0 0.2 0.6 9.8 2.4 0.4 2.8 0.3 0 0
Deferred Revenue 0 0 0 0 0 0 2.6 3.1 0 0
Other Current Liabilities 5.6 0.0 2.2 0.0 2.8 2.0 0.2 0.2 0.0 0.0
Total Current Liabilities 14.9 13.1 7.4 14.8 9.3 5.2 6.7 5.2 3.7 2.0
Non-Current Liabilities
Long-Term Debt 51.4 38.8 36.8 7.4 16.9 18.9 6.8 9.1 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 26.9 4.0 7.5 0.4 0.2 0.8 0.2 0.1 73.1 18.1
Total Non-Current Liabilities 79.3 44.1 44.3 7.7 17.6 20.7 8.3 10.8 73.1 18.1
Total Liabilities 94.2 57.3 51.8 22.6 26.9 25.9 15.0 16.1 76.8 20.1
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (366.5) (281.3) (226.5) (189.7) (161.7) (129.5) (96.5) (67.0) (43.2) (18.8)
Accumulated Other Comprehensive Income 0 (0.0) 0.0 (0.0) 0.0 0 0 (0.0) (0.0) (0.0)
Total Stockholders' Equity 13.3 37.2 72.4 56.5 82.2 51.4 78.7 106.0 (37.1) (18.2)
Total Liabilities & Equity 107.5 94.5 124.2 79.0 109.0 77.3 93.8 122.0 39.8 1.8
Debt Metrics
Total Debt 52.7 40.3 37.4 17.6 20.2 20.3 11.3 11.3 0 0
Net Debt (23.0) (6.5) (33.7) (56.6) (85.1) (52.5) (78.3) (107.0) (39.3) (1.6)
Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Operating Activities
Net Income (85.1) (54.8) (36.8) (28.0) (32.2) (33.0) (29.4) (23.8) (24.4) (10.5)
Depreciation & Amortization 0.0 0.6 0.5 0.4 0.4 0.4 0.3 0.2 0.0 0.0
Stock-Based Compensation 5.4 4.9 2.8 2.4 2 1.4 2.1 0.9 0.9 0.4
Change in Working Capital (13.1) (6.3) (0.3) (2.6) 1.4 0.4 (2.2) (0.2) 1.5 0.9
Other Non-Cash Items 22.2 (3.6) (0.7) 0.7 0.6 0.4 0.4 0.2 6.5 (0.4)
Operating Cash Flow (70.5) (59.2) (34.6) (27.2) (27.7) (30.4) (28.8) (22.7) (15.5) (9.6)
Investing Activities
Capital Expenditure (0.0) (0.0) (0.0) (0.0) 0 0 0 (0.2) (0.0) (0.0)
Acquisitions 0 0 45.8 (32.1) 0 0 0 0 0 0
Purchases of Investments 0 (50.6) (67.5) (9.0) (72.2) 0 0 0 0 0
Sales/Maturities of Investments 29.3 70.6 21.7 41.1 38.7 0 0 0 0 0
Other Investing Activities 0 0 (45.8) 32.1 0 0 0 0 0 0
Investing Cash Flow 29.3 20.0 (45.9) 32.1 (33.5) 0 0 (0.2) (0.0) (0.0)
Financing Activities
Net Debt Issuance (3.2) 0 29.8 (2.5) 0 9.6 (0.1) 9.3 12.6 0
Stock Repurchased 0 0 0 0 (0.2) 0 (0.0) (0.0) 0 (0.0)
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 19.8 0.8 (0.3) (0.1) (0.2) 0.1 0.1 0.1 (0.4) 0.0
Financing Cash Flow 70.1 14.8 77.2 (2.5) 60.3 13.6 (0.0) 102.1 53.2 8.0
Cash Position
Net Change in Cash 28.8 (24.4) (3.2) 2.4 (0.8) (16.9) (28.8) 79.2 37.7 (1.6)
Cash at Beginning 46.8 71.2 74.5 72.0 72.8 89.7 118.5 39.3 1.6 3.2
Cash at End 75.7 46.8 71.2 74.5 72.0 72.8 89.7 118.5 39.3 1.6
Free Cash Flow (70.6) (59.3) (34.6) (27.2) (27.7) (30.4) (28.8) (22.9) (15.5) (9.7)
Key Metrics 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Income Statement
Revenue 36.3 13.6 0 0 0 0 0 0 0 0
Gross Profit 25.0 9.8 (0.5) (0.4) (0.4) (0.4) (0.3) (0.2) (0.0) (0.0)
Operating Income (64.8) (55.4) (36.2) (25.8) (29.9) (32.9) (29.7) (23.4) (17.9) (10.8)
Net Income (85.1) (54.8) (36.8) (28.0) (32.2) (34.4) (29.4) (23.8) (24.4) (10.5)
EPS (Diluted) -1.91 -1.42 -1.30 -1.02 -1.31 -1.85 -1.59 -8.04 -2.18 -0.94
Balance Sheet
Cash & Equivalents 75.7 46.8 71.1 74.3 71.8 72.8 89.7 118.3 39.3 1.6
Total Assets 107.5 94.5 124.2 79.0 109.0 77.3 93.8 122.0 39.8 1.8
Total Debt 52.7 40.3 37.4 17.6 20.2 20.3 11.3 11.3 0 0
Stockholders' Equity 13.3 37.2 72.4 56.5 82.2 51.4 78.7 106.0 (37.1) (18.2)
Cash Flow
Operating Cash Flow (70.5) (59.2) (34.6) (27.2) (27.7) (30.4) (28.8) (22.7) (15.5) (9.6)
Capital Expenditure (0.0) (0.0) (0.0) (0.0) 0 0 0 (0.2) (0.0) (0.0)
Free Cash Flow (70.6) (59.3) (34.6) (27.2) (27.7) (30.4) (28.8) (22.9) (15.5) (9.7)